Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.

ABSTRACT:

SUBMITTER: Groome MJ 

PROVIDER: S-EPMC7322558 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature